AChR Antibody Test: How Myasthenia Gravis Is Diagnosed

What Is an AChR Antibody Test?

An AChR antibody test detects autoantibodies that attack the acetylcholine receptor, the docking site where nerve signals tell muscles to contract. In myasthenia gravis, these antibodies block or destroy receptors, so muscles weaken with use and recover partly with rest. The classic pattern is drooping eyelids, double vision, and weakness that worsens through the day.

The most common assay measures the binding antibody, which is present in the large majority of people with generalized myasthenia gravis. The test is a standard blood draw. This is educational information, not medical advice, and suspected myasthenia gravis deserves prompt neurological evaluation.

Why an AChR Test Is Ordered

• Drooping eyelids or double vision that comes and goes
• Weakness in chewing, swallowing, speaking, or neck muscles
• Arm or leg weakness that worsens with activity and improves with rest
• Confirming suspected myasthenia gravis before treatment
• Evaluating a chest mass for thymoma in someone with muscle weakness

Because myasthenia gravis can affect breathing and swallowing, new or worsening symptoms should be assessed urgently rather than through routine testing alone.

What Positive and Negative Results Mean

A positive binding antibody result strongly supports a diagnosis of myasthenia gravis in someone with matching symptoms. Higher levels do not always track symptom severity, so the number guides diagnosis more than day-to-day management.

Reference cutoffs vary by laboratory, so results are read against the range on your own report.

Binding, Blocking, and Modulating Antibodies

Labs can measure three types of AChR antibodies, and the binding assay is the one used most often. Binding antibodies attach to the receptor and are the most sensitive single test. Blocking antibodies prevent acetylcholine from docking, and modulating antibodies speed up the loss of receptors from the muscle surface. The blocking and modulating assays are less widely used, but a clinician may add them when the binding result is negative and suspicion remains.

Because the binding test catches the large majority of generalized cases, it is usually the first step. Knowing which type is present can help explain the pattern of weakness, but it does not change the basic diagnosis once symptoms and antibody results line up.

Related Antibody and Confirmatory Tests

When AChR binding antibodies are negative but suspicion stays high, clinicians may order MuSK antibodies, LRP4 antibodies, or striational antibodies. Electrical testing such as repetitive nerve stimulation or single-fiber EMG, performed by a neurologist, can confirm impaired nerve-to-muscle transmission.

Chest imaging is also common at diagnosis because a fraction of patients have a thymoma, a tumor of the thymus gland associated with the disease. These follow-up steps need a clinician, since direct-access labs cover the blood work only.

How to Order an AChR Test and Where to Get Tested

AChR testing can be ordered by a neurologist or through direct-access lab testing, where you order online and visit a local collection site for the blood draw. Results typically take several business days because antibody assays are run in batches at specialty labs.

If you have trouble breathing, swallowing, or holding your head up, seek urgent care first and treat the blood test as follow-up. Bring a list of current drugs, since some medications can worsen myasthenic weakness.

How Much Does an AChR Test Cost?

Direct-access AChR binding antibody testing commonly costs between about $100 and $250, reflecting the specialized assay. Broader myasthenia panels that add MuSK or striational antibodies cost more but can save a second round of testing when the first result is negative.

Insurance often covers the test when a clinician documents compatible symptoms. For direct-access orders, confirm whether the collection fee is included in the quoted price.

What to Expect at the Blood Draw

The AChR test needs only a standard blood draw, so no fasting or special preparation is required. Because antibody assays are run in batches at specialty laboratories, results often take several business days and sometimes longer than a routine chemistry panel. A single tube is usually enough, and the sample is stable once it reaches the lab, so a normal collection visit is all that is needed.

Timing relative to treatment matters more than timing relative to meals. If you are already receiving immune therapy, tell the ordering clinician so the result is read in context. Keep a copy of the report, since reference ranges differ between laboratories and a neurologist will want the exact cutoff used.

Factors That Can Shift AChR Results

AChR antibody levels are fairly stable, but a few things deserve attention. Immunosuppressive drugs and recent plasma exchange or IVIG treatment can lower antibody levels and mask the result, so timing relative to treatment matters. Recent infections or vaccinations can stir general immune activity without changing the specific diagnosis.

Sample handling matters too, since antibody assays are sensitive tests run at specialty labs. A hemolyzed or long delayed sample may need recollection. If the result conflicts strongly with symptoms, repeating the test at a different laboratory is reasonable before closing the question.

Living With a New Myasthenia Gravis Diagnosis

A new diagnosis usually leads to neurology follow up, chest imaging, and a treatment plan built around drugs that improve nerve to muscle signaling plus immune therapy when needed. Many people keep a symptom diary noting eyelid droop, swallowing, speech, and limb strength through the day, which helps the neurologist tune treatment. This is educational information, not medical advice, and breathing or swallowing trouble always deserves urgent care.